There are few studies which have examined treatment pattern and outcomes of exudative maculopathy specifically in Asians, although it is often assumed that similar results with anti-VEGF therapy can be expected for eyes with choroidal neovascularization secondary to typical AMD (AMD-CNV) while different treatment appears to be required for the polypoidal choroidal vasculopathy (PCV) subtype [19]–[20]. Here, VEGFA is linked to Polypoidal choroidal vasculopathy.